论文信息 - Significant response of pituitary carcinoma to carboplatin, leucovorin and fluorouracil chemotherapy: a pediatric case report and review of the literature - 字舞流文

Significant response of pituitary carcinoma to carboplatin, leucovorin and fluorouracil chemotherapy: a pediatric case report and review of the literature

M. Okcu | S. Waguespack | D. Baskin | Jeremy Jones | Mohamed S. Abdelbaki | S. Stapleton | Violeta Salceda

[1] B. Scheithauer,et al. Anti-VEGF therapy in pituitary carcinoma , 2012, Pituitary.

[2] F. Ducray,et al. New targeted therapies in pituitary carcinoma resistant to temozolomide , 2012, Pituitary.

[3] A. Heaney. Pituitary Carcinoma: Difficult Diagnosis and Treatment , 2011 .

[4] M. Korbonits,et al. Activation of RAF/MEK/ERK and PI3K/AKT/mTOR pathways in pituitary adenomas and their effects on downstream effectors. , 2009, Endocrine-related cancer.

[5] H. Shahinian,et al. Temozolomide: a novel treatment for pituitary carcinoma. , 2006, The Lancet. Oncology.

[6] J. Franklyn,et al. Vascular endothelial growth factor, its receptor KDR/Flk-1, and pituitary tumor transforming gene in pituitary tumors. , 2002, The Journal of clinical endocrinology and metabolism.